Levetiracetam Stada (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a crucial role in neurotransmitter release. By modulating SV2A activity, the drug stabilises neuronal firing and diminishes excessive excitability, thereby lowering the risk of seizure initiation and spread across the brain.

The specific dose of Levetiracetam Stada is determined by the prescribing clinician based on the patient’s age, weight, renal function, seizure type, and response to therapy. Healthcare professionals tailor the regimen to achieve optimal seizure control while minimising side effects.

Safety data for levetiracetam in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Levetiracetam offers a favourable safety profile and minimal drug‑enzyme interactions compared with many older antiepileptics such as carbamazepine or phenytoin. It is often preferred when clinicians seek a medication with fewer hepatic metabolism concerns, though individual response and tolerability ultimately guide drug selection.

Levetiracetam Stada should be stored at ambient temperature below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Levetiracetam Stada is taken orally, usually as a whole tablet swallowed with water. It can be taken with or without food, but patients should follow the prescribing information and maintain a consistent dosing schedule to ensure stable blood levels.

Serious adverse events, although rare, include severe allergic reactions such as Stevens‑Johnson syndrome, suicidal thoughts or behaviours, significant skin rashes, and blood dyscrasias like neutropenia. Patients should seek immediate medical attention if they notice any of these symptoms.

Levetiracetam Stada is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment who may require dose adjustment, and for those with a history of psychiatric disorders who need close monitoring.